Molecular aspects of glucose homeostasis in skeletal muscle - A focus on the molecular mechanisms of insulin resistance

Molecular and Cellular Endocrinology

Volumn 417, Issue , 2015, Pages 52-62

  Carnagarin, Revathy ^a,b   Dharmarajan, Arun M ^a,b   Dass, Crispin R ^a,b  

^a Curtin Biosciences Research Precinct   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

GLUT4; Insulin; Insulin resistance; Metabolism

Indexed keywords

GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE B; RAC1 PROTEIN; GLUCOSE; SLC2A4 PROTEIN, HUMAN;

AUTOPHOSPHORYLATION; ENZYME ACTIVATION; FEEDBACK SYSTEM; GLUCOSE HOMEOSTASIS; INSULIN RESISTANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; ANIMAL; HOMEOSTASIS; HUMAN; METABOLISM;

ANIMALS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL;

EID: 84960197377     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.09.004     Document Type: Review

References (140)

1. Aguirre V., et al. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 2000, 275:9047-9054.
2. Aguirre V., et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 2002, 277:1531-1537.
3. Bar R.S., et al. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv. Intern. Med. 1979, 24:23-52.
4. Barbour L., et al. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J. Biol. Chem. 2005, 280:37489-37494.
5. Baumann C.A., et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207.
6. Bokoch G.M. Biology of the p21-activated kinases. Ann. Rev. Biochem. 2003, 72:743-781.
7. Bouzakri K., et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 2003, 52:1319-1325.
8. Bouzakri K., et al. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab. 2006, 4:89-96.
9. Braccini L., et al. PI3K keeps the balance between metabolism and cancer. Adv. Biol. Regul. 2012, 52:389-405.
10. Bryant N.J., et al. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002, 3:267-277.
11. Cai D., et al. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK. J. Biol. Chem. 2003, 278:25323-25330.
12. Chen X.W., et al. Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev. Cell. 2007, 13:391-404.
13. Chiang S.H., et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001, 410:944-948.
14. Chiu T.T., et al. Arp2/3- and cofilin-coordinated actin dynamics is required for insulin-mediated GLUT4 translocation to the surface of muscle cells. Mol. Biol. Cell 2010, 21:3529-3539.
15. Chunqiu Hou J., Pessin J.E. Lipid raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin. Mol. Biol. Cell 2003, 14:3578-3591.
16. Cocozza S., et al. NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes 1992, 41:521-526.
17. Coffer P.J., et al. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 1998, 335:1-13.
18. Copps K.D., White M.F. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012, 55:2565-2582.
19. Cornier M.A., et al. Nutritional up-regulation of p85α expression is an early molecular manifestation of insulin resistance. Diabetologia 2006, 49:748-754.
20. Cross D.A., et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
21. DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32:S157-S163.
22. Dharmawardhane S., et al. Localization of p21-Activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells. J. Cell Biol. 1997, 138:1265-1278.
23. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85α: the two sides of a Coin. Diabetes 2006, 55:2392-2397.
24. Du K., et al. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577.
25. Elcheby M., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
26. Eldar-Finkelman H., et al. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem. 1995, 270:987-990.
27. Eldar-Finkelman H., et al. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 1999, 48:1662-1666.
28. Eldar-Finkelman H., Kaidanovich O. The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes. Expert Opin. Ther. Targets 2002, 6:555-561.
29. Fallah F.J., et al. The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH Domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation. Mol. Cell Biol. 2002, 22:7325-7336.
30. Fang X., et al. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci U. S. A. 2000, 97:11960-11965.
31. Fang D., Liu Y.C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2001, 2:870-875.
32. Federici M., et al. Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. Diabetes 1998, 47:87-92.
33. Foster L.J., et al. Insulin-dependent interactions of proteins withGLUT4 revealed through stable isotope labeling by amino acids in cell culture (SILAC). J. Proteome Res. 2006, 5:64-75.
34. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 2001, 359:1-16.
35. Freidenberg G.R., et al. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J. Clin. Invest. 1988, 82:1398-1406.
36. Gao T., et al. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 2005, 18:13-24.
37. Giorgino F., et al. Specific increase in p85α expression in response to dexamethazone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. J. Biol. Chem. 1997, 272:7455-7463.
38. Giraud J., et al. Phosphorylation of Irs1 at SER-522 inhibits insulin signaling. Mol. Endocrinol. 2007, 21:2294-2302.
39. Goode N., et al. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J. Biol. Chem. 1992, 267:16878-16882.
40. Gotoh T., et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell Biol. 1995, 15:6746-6753.
41. Greene M.W., et al. PKCδ-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem. Res. Commun. 2006, 349:976-986.
42. Grunberger G., et al. Insulin receptors in normal and disease states. Clin. Endocrinol. Metab. 1983, 12:191-219.
43. Gual P., et al. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87:99-109.
44. Gustafson T.A., et al. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell Biol. 1995, 15:2500-2508.
45. Hajduch E., et al. Protein kinase B (PKB/Akt) - a key regulator of glucose transport?. FEBS Lett. 2001, 492:199-203.
46. Halfon B.S., Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E581-E591.
47. Haruta T., et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 2000, 14:783-794.
48. Hirashima Y., et al. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 2003, 179:253-266.
49. Hotamisligil G.S., et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 1994, 94:1543-1549.
50. Hruz P.W., Mueckler M.M. Structural analysis of the GLUT1 facilitative glucose transporter (review). Mol. Membr. Biol. 2001, 18:183-193.
51. Huang C., et al. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in L6 myotubes. J. Biol. Chem. 2005, 280:19426-19435.
52. Hubbard S.R., et al. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994, 372:746-754.
53. Inoue G., et al. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J. Biol. Chem. 1998, 273:11548-11555.
54. Ishikura S., et al. Rabs 8A and 14 are targets of the insulin-regulated Rab-GAP AS160 regulating GLUT4 traffic in muscle cells. Biochem. Res. Commun. 2007, 353:1074-1079.
55. Ishikura S., Klip A. Muscle cells engage Rab8A and myosin Vb in insulin-dependent GLUT4 translocation. Am. J. Physiol. Cell Physiol. 2008, 295:C1016-C1025.
56. JeBailey L., et al. Skeletal muscle cells and adipocytes differ in their Reliance on TC10 and Rac for insulin-induced actin remodeling. Mol. Endocrinol. 2004, 18:359-372.
57. JeBailey L., et al. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes 2007, 56:394-403.
58. Joost H.G., Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr. Biol. 2001, 18:247-256.
59. Kahn C.R. Role of insulin receptors in insulin-resistant states. Metab. Clin. Exp. 1980, 29:455-466.
60. Kaplan S.A. The insulin receptor. J. Pediatr. 1984, 104:327-336.
61. Katso R., et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Ann. Rev. Cell Dev. Biol. 2001, 17:615-675.
62. Khayat Z.A., et al. Insulin-induced actin filament remodelingcolocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes. J. Cell Sci. 2000, 113:279-290.
63. Kim Y.B., et al. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes 2003, 52:1935-1942.
64. Kim J., et al. Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by mouse pelle-like kinase/interleukin-1 receptor-associated kinase: cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance. J. Biol. Chem. 2005, 280:23173-23183.
65. Kitamura T., et al. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell Biol. 1998, 18:3708-3717.
66. Knudsen B.S., et al. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J. Biol. Chem. 1994, 269:32781-32787.
67. Kotani K., et al. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell Biol. 1998, 18:6971-6982.
68. Kramer H.F., et al. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 2006, 55:2067-2076.
69. Kristensen C., et al. Expression and characterization of a 70-kDa fragment of the Insulin receptor that binds insulin: minimizing ligand binding domain of the insulin receptor. J. Biol. Chem. 1998, 273:17780-17786.
70. Krook A., et al. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997, 46:2110-2114.
71. Kuo Y.C., et al. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J. Biol. Chem. 2008, 283:1882-1892.
72. Kurowski T.G., et al. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes 1999, 48:658-663.
73. Lalioti V., et al. Targeting motifs in GLUT4 (review). Mol. Membr. Biol. 2001, 18:257-264.
74. Lietzke S.E., et al. Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains. Mol. Cell 2000, 6:385-394.
75. Lim S.N., et al. Identification of discrete classes of endosome-derived small vesicles as a major cellular pool for recycling membrane proteins. Mol. Biol. Cell 2001, 12:981-995.
76. Liu L.Z., et al. Protein kinase Czeta mediates insulin-induced glucose transport through actin remodeling in L6 muscle cells. Mol. Biol. Cell 2006, 17:2322-2330.
77. Lodhi I.J., et al. Gapex-5, a Rab31 guanine nucleotide exchange factor that regulates Glut4 trafficking in adipocytes. Cell Metab. 2007, 5:59-72.
78. Luo J., et al. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J. Cell Biol. 2005, 170:455-464.
79. Luttrell L., et al. Effect of cellular expression of pleckstrin homology domains on Gi-coupled receptor signaling. J. Biol. Chem. 1995, 270:12984-12989.
80. Mackay D.J., Hall A. Rho GTPases. J. Biol. Chem. 1998, 273:20685-20688.
81. Maffucci T., et al. Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO J. 2003, 22:4178-4189.
82. Marcusohn J., et al. The GTP-binding protein Rac does not couple PI 3-kinase to insulin-stimulated glucose transport in adipocytes. Curr. Biol. 1995, 5:1296-1302.
83. Melvin D.R., et al. Analysis of amino and carboxy terminal GLUT-4 targeting motifs in 3T3-L1 adipocytes using an endosomal ablation technique. Biochemistry 1999, 38:1456-1462.
84. Mohan S.S., et al. Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors. J. Biomol. Struct. Dyn. 2009, 26:455-464.
85. Mora A., et al. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 2004, 15:161-170.
86. Morfini G., et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 2002, 21:281-293.
87. Mothe I., Van Obberghen E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 1996, 271:11222-11227.
88. Myers M.G., et al. The pleckstrin homology domain in IRS-l sensitizes insulin signaling. J. Biol. Chem. 1995, 270:11715-11718.
89. Nawaratne R., et al. Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation. Mol. Endocrinol. 2006, 20:1838-1852.
90. Neudauer CL., et al.. Distinct cellular effects and interactions of the Rho-family GTPase TC10. Curr. Biol. 199; 8:1151-1160.
91. Nikoulina S.E., et al. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 2000, 49:263-271.
92. Nishita M., et al. Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration. J. Cell Biol. 2005, 171:349-359.
93. Nozaki S., et al. Role of RalA downstream of Rac1 in insulin-dependent glucose uptake in muscle cells. Cell Signal 2012, 24:2111-2117.
94. Ogihara T., et al. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J. Biol. Chem. 1997, 272:25267-25274.
95. Olson A.L., et al. Syntaxin 4, VAMP2, and/or VAMP3/cellubrevin are functional target membrane and vesicle SNAP receptors for insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell Biol. 1997, 17:2425-2435.
96. O'Rahilly S., et al. Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes 1991, 40:777-782.
97. O'Rahilly S., et al. Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a welsh type 2 (non-insulin-dependent) diabetic population. Diabetologia 1992, 35:486-489.
98. Pessin J.E., Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 2000, 106:165-169.
99. Peterson R.T., Schreiber S.L. Kinase phosphorylation: keeping it all in the family. Curr. Biol. 1999, 9:R521-R524.
100. Pitcher J.A., et al. Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G-beta/gamma subunits and lipid. J. Biol. Chem. 1995, 270:11707-11710.
101. Ploug T., et al. Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions. J. Cell Biol. 1998, 142:1429-1446.
102. Qiao L.Y., et al. Identification of enhanced serine kinase activity in insulin resistance. J. Biol. Chem. 1999, 274:10625-10632.
103. Randhawa V.K., et al. GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells. J. Biol. Chem. 2008, 283:27208-27219.
104. Ribon V., et al. A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol. Cell Biol. 1998, 18:872-879.
105. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
106. Sano H., et al. Insulin-stimulated phosphorylation of a RabGTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 2003, 278:14599-14602.
107. Sarbassov D.D., et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
108. Seabra M.C., Wasmeier C. Controlling the location and activation of RabGTPases. Curr. Opin. Cell Biol. 2004, 16:451-457.
109. Semenova I., et al. Actin dynamics is essential for myosin-based transport of membrane organelles. Curr. Biol. 2008, 18:1581-1586.
110. Sesti G., et al. Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes Metab. Res. Rev. 2001, 17:363-373.
111. Shao J., et al. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J. Endocrinol. 2000, 167:107-115.
112. Shepherd P.R., et al. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 1998, 333:471-490.
113. Shimomura I., et al. Decreased IRS-2 and increased SREBP-1c Lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 2000, 6:77-86.
114. Sidani M., et al. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J. Cell Biol. 2007, 179:777-791.
115. Sommerfeld M.R., et al. Vitro phosphorylation of insulin receptor substrate 1 by protein kinase C-ζ: functional analysis and identification of novel phosphorylation sites. Biochemistry 2004, 43:5888-5901.
116. Storz P., et al. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells. Palmitate rather than tumor necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur. J. Biochem. 1999, 266:17-25.
117. Stuart C.A., et al. Comparison of GLUT1, GLUT3, and GLUT4 mRNA and the subcellular distribution of their proteins in normal human muscle. Metab. Clin. Exp. 2000, 49:1604-1609.
118. Stuart C.A., et al. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1067-E1073.
119. Sun X.J., et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995, 377:173-177.
120. Sun Y., et al. Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19909-19914.
121. Sylow L., et al. Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle. Diabetes 2013, 62:1865-1875.
122. Taylor S.I., et al. Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care 1990, 13:257-279.
123. Teruel T., et al. Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 2001, 50:2563-2571.
124. Thirone A.C., et al. Regulation of Cbl-associated protein/Cbl pathway in muscle and adipose tissues of two animal models of insulin resistance. Endocrinology 2004, 145:281-293.
125. Thong F.S., et al. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiol. Bethesda 2005, 20:271-284.
126. Tremblay F., et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14056-14061.
127. Ueki K., et al. Positive and negative roles of p85α and p85β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J. Biol. Chem. 2003, 278:48453-48466.
128. Um S.H., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004, 43:200-205.
129. Vanhaesebroeck B., et al. Synthesis and function of 3-phosphorylated inositol lipids. Ann. Rev. Biochem. 2001, 70:535-602.
130. Verhelle S.D., et al. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591786. J. Biol. Chem. 1996, 271:5980-5983.
131. Walker, et al. Activation of protein kinase B β and γ isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B α. Biochem. J. 1998, 331:299-308.
132. Wang Z., et al. Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo. J. Biol. Chem. 2011, 286:41359-41367.
133. White M.F., et al. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem. 1988, 263:2969-2980.
134. White M.F., Kahn C.R. The insulin signaling system. J. Biol. Chem. 1994, 269:1-4.
135. Wood I.S., Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. J. Nutr. 2003, 89:3-9.
136. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990, 9:2431-2438.
137. Yuan M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 2001, 293:1673-1677.
138. Zheng Y., et al. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 1994, 269:18727-18730.
139. Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 2001, 11:437-441.
140. Ziegler S.F., et al. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 1993, 8:663-670.